Literature DB >> 2887082

Paragangliomas of the craniocervical region. An immunohistochemical study on tyrosine hydroxylase.

H Takahashi, S Nakashima, T Kumanishi, F Ikuta.   

Abstract

An immunohistochemical study on tyrosine hydroxylase (TH), a rate-limiting enzyme in the catecholamine synthesizing pathway, was made on three craniocervical region paragangliomas, two of which showed metastases to the cervical lymph nodes. In all of the original tumors, the majority of tumor cells showed positive immunostaining for TH of variable intensity in their cytoplasm regardless of their cytological features such as cellular and nuclear pleomorphism. The finding suggests that most tumor cells are capable of production of catecholamines and are derived from chief cells in the normal paraganglia. In cervical lymph nodes, however, no positive immunostaining for TH was observed in metastatic tumor cells, in contrast with the findings in the original tumors. The absence of TH immunoreactivity in metastatic tumor cells appears to be noteworthy in considering their malignant potential. Application of the TH immunohistochemistry to further cases appears important for the better understanding of this neoplasm, a catecholamine-producing tumor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887082     DOI: 10.1007/bf00686615

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  36 in total

1.  CYTOCHEMICAL DEMONSTRATION OF CATECHOLAMINES IN THE HUMAN CAROTID BODY.

Authors:  M NIEMI; K OJALA
Journal:  Nature       Date:  1964-08-01       Impact factor: 49.962

2.  Chemodectoma of the vagus nerve. Report of a case with ultrastructural study.

Authors:  B B Fernandez; F J Hernandez; C J Staley
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

3.  Mediastinal paragangliomas (aortic body tumor): a report of four cases and a review of the literature.

Authors:  J L Olson; W R Salyer
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

4.  Studies on the role of dopamine in cardiovascular and respiratory control: central versus peripheral mechanisms.

Authors:  P Bolme; K Fuxe; T Hökfelt; M Goldstein
Journal:  Adv Biochem Psychopharmacol       Date:  1977

5.  Chemodectomas (nonchromaffin paragangliomas) of the head and neck. A clinicopathologic study.

Authors:  H A Oberman; F Holtz; L A Sheffer; J E Magielski
Journal:  Cancer       Date:  1968-05       Impact factor: 6.860

6.  Comparative cytological studies of the carotid body. 1. Demonstration of monoamine-storing cells by correlated chromaffin reaction and fluorescence histochemistry.

Authors:  S Kobayashi
Journal:  Arch Histol Jpn       Date:  1971-10

7.  Catecholamine-synthesizing enzymes in paraganglia of aged Fischer-344 rats. Immunohistochemistry and fluorescence microscopy.

Authors:  M Partanen; S I Rapoport; D J Reis; T H Joh; J M Stolk; I Linnoila; G Teitelman; A Hervonen
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

8.  Vagal body tumor (nonchromaffin paraganglioma, chemodectoma, and carotid body-like tumor) with cervical node metastasis and familial association: ultrastructural study and review.

Authors:  L B Kahn
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

9.  The distribution and endocrine nature of the abdominal paraganglia of adult man.

Authors:  A Hervonen; S Partanen; A Vaalasti; M Partanen; L Kanerva; H Alho
Journal:  Am J Anat       Date:  1978-12

10.  [Topography of the catecholamine neurons in the brain stem of the human fetus: an immunohistochemical study using antibodies to tyrosine hydroxylase].

Authors:  H Takahashi; S Nakashima; E Ohama; S Takeda; F Ikuta
Journal:  No To Shinkei       Date:  1986-01
View more
  9 in total

1.  Management of metastatic glomus jugulare tumors.

Authors:  D I Bojrab; S A Bhansali; R J Zarbo
Journal:  Skull Base Surg       Date:  1992

2.  Esthesioneuroblastoma: a nasal catecholamine-producing tumor of neural crest origin. Demonstration of tyrosine hydroxylase-immunoreactive tumor cells.

Authors:  H Takahashi; K Wakabayashi; F Ikuta; K Tanimura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Melanotic paraganglioma of the orbit: a case report.

Authors:  W Paulus; K Jellinger; H Brenner
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma.

Authors:  N Kimura; Y Miura; I Nagatsu; H Nagura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  Neuroendocrine markers in central nervous system neuronal tumors (gangliocytoma and ganglioglioma).

Authors:  H Takahashi; K Wakabayashi; K Kawai; F Ikuta; R Tanaka; N Takeda; K Washiyama
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.

Authors:  Henri J L M Timmers; Karel Pacak; Thanh T Huynh; Mones Abu-Asab; Maria Tsokos; Maria J Merino; Bora E Baysal; Karen T Adams; Graeme Eisenhofer
Journal:  J Clin Endocrinol Metab       Date:  2008-10-07       Impact factor: 5.958

7.  Immunocytochemical demonstration of IGF-II-like immunoreactivity in human paraganglioma of the craniocervical region.

Authors:  T Suzuki; M Iwafuchi; H Takahashi; F Ikuta; K Nishikawa; H Tanaka; N Yanaihara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

8.  Esthesioneuroepithelioma: a tumor of true olfactory epithelium origin. An ultrastructural and immunohistochemical study.

Authors:  H Takahashi; S Ohara; M Yamada; F Ikuta; K Tanimura; Y Honda
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

9.  Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma.

Authors:  Xin Gao; Yuto Yamazaki; Alessio Pecori; Yuta Tezuka; Yoshikiyo Ono; Kei Omata; Ryo Morimoto; Yasuhiro Nakamura; Fumitoshi Satoh; Hironobu Sasano
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-10       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.